Pheophorbide A
Based on 2 publication(s) in Google Scholar
Pheophorbide A is an intermediate product in the chlorophyll degradation pathway. Pheophorbide A can be used as a photosensitizer. Pheophorbide A is a lymphatic vascular activator. Pheophorbide A has antitumor activity. Pheophorbide A can be used for human lymphatic vascular insufficiencies research.
For research use only. We do not sell to patients.
- Purity: 98.20%
- CAS No.: 15664-29-6
- Formula: C35H36N4O5
- Molecular Weight:592.68
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Natural Product Library
HY-L021
-
Anti-Cancer Compound Library
HY-L025
-
Macrocyclic Compound Library
HY-L041
-
Microbial Metabolite Library
HY-L084
-
Anti-Cancer Natural Product Library
HY-L107
-
Cell Death Library
HY-L162
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Natural Product Diversity Scaffold Library
HY-L245
-
Mass Spectrometry Natural Product Library
HY-L262
Publications Citing Use of MedChemExpress (MCE) Pheophorbide A
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 1A9 | ED50 |
0.48 μg/mL
Compound: 2
|
Cytotoxicity against human 1A9 cells after 72 hrs by SRB assay
Cytotoxicity against human 1A9 cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
| A549 | ED50 |
1.5 μg/mL
Compound: 2
|
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
| HCT-8 | ED50 |
1.5 μg/mL
Compound: 2
|
Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay
Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
| KB | ED50 |
0.46 μg/mL
Compound: 2
|
Cytotoxicity against human KB cells after 72 hrs by SRB assay
Cytotoxicity against human KB cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
| MCF7 | ED50 |
1.6 μg/mL
Compound: 2
|
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
| SK-MEL | ED50 |
0.91 μg/mL
Compound: 2
|
Cytotoxicity against human SK-MEL cells after 72 hrs by SRB assay
Cytotoxicity against human SK-MEL cells after 72 hrs by SRB assay
|
[PMID: 11473423] |
Pheophorbide A (10 µM) increases lymphatic endothelial cells (LECs) sprouting, proliferation and tube formation[1].
Pheophorbide A-mediated photodynamic therapy (Pa-PDT) inhibits cellular growth on Hep3B, in a dose-dependent manner with an IC50 of 1.5 μM[2].
Pheophorbide A (2 µM, 24 h) induces apoptosis in Hep3B cells after photo-activation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male immunocompetent C3H mouse (six-week-old, inoculated subcutaneously with AT-84 cells)[3]
-
Dosage:10 mg/kg intravenous (i.v.) or a 30 mg/kg intraperitoneal (i.p.) injection
-
Administration:IV or IP; after 24 h, PDT was performed
-
Result:Pa-PDT, especially i.v. Pa-PDT, significantly inhibited tumor growth up to 70%, while the i.p. Pa-PDT-induced inhibition was up to 43.4% relative to the control group at the end of period.
Chemical Information
-
CAS No. 15664-29-6
-
Appearance Solid
-
Molecular Weight 592.68
-
Formula C35H36N4O5
-
Color Blue to dark blue
-
SMILES
O=C([C@@H]1/C(C(NC(/C=C2C(CC)=C3C)=C4C)=C4C1=O)=C(N=C(/C=C(C(C)=C/5C=C)\NC5=C/C3=N/2)[C@H]6C)\[C@H]6CCC(O)=O)OC
-
Structure Classification
-
Initial Source
Botrytis cinerea
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
DMSO : 2 mg/mL (3.37 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Methanol : < 1 mg/mL (insoluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (281 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Jihye Kim, et al. Pheophorbide a identified in an Eupatorium perfoliatum extract is a novel lymphatic vascular activator. Biomed Pharmacother. 2022 Mar;147:112664. [Content Brief]
[2]. Tang PM, et al. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther. 2006 Sep;5(9):1111-6. [Content Brief]
[3]. Ahn MY, et al. Pheophorbide a-mediated photodynamic therapy induces apoptotic cell death in murine oral squamous cell carcinoma in vitro and in vivo. Oncol Rep. 2012 Jun;27(6):1772-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6873 mL | 8.4363 mL | 16.8725 mL | 42.1813 mL |
Pheophorbide A Related Classifications
HY-125665 Related Classifications
Powered by Bioz